Summary
Following previous findings in human skin of the functional expression of genes for the corticotropin releasing hormone (CHR) receptor type 1 (CRH-R1) and CRH itself, we searched for local phenotypic effects for peptides related to CRH. We now report that CRH, sauvagine, and urocortin inhibit proliferation of human HaCaT keratinocytes in a dose-dependent manner. The peptides produced variable cyclic adenosine 3′∶5′-monophosphate stimulation with CRH having the highest potency. Binding of iodine 125 CRH to intact keratinocytes was inhibited by increasing doses of CRH, sauvagine, or urocortin, all showing equal inhibitory potency. Immunocytochemistry identified CRH-R1 immunoreactivity in HaCaT keratinocytes. In conclusion, CRH (exogenous or produced locally) and the related urocortin and sauvagine peptides can modify human keratinocyte phenotype through a receptor-mediated pathway.
Similar content being viewed by others
References
Aguilera, G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol. 9:329–336; 1998.
Chalmers, D. T.; Lovenberg, T. W.; Grigoriadis, D. E.; Behan, D. P.; De Souza, E. B. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17:166–172; 1996.
Chen, R.; Lewis, K. A.; Perrin, M. H.; Vale, W. W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA 90:8967–8971; 1993
Fazal, N.; Slominski, A.; Choudhry, M. A.; Wei, E. T.; Sayeed, M. M. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett. 435:187–190; 1998.
Kiang, J. Corticotropin-releasing factor increases [Ca2+] via receptor-mediated Ca2+ channels in human epidermoid A-431 cells. Eur J. Pharmacol. 267:135-`42; 1994.
Kiang, J. G. Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells. Eur. J. Pharmacol. 329; 237–244; 1997.
Kishimoto, T.; Pearse, R. V.; Lin, C. R.; Rosenfeld, M. G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92:1108–1112; 1995.
Lovenberg, T. W.; Liaw, C. W.; Grigoriadis, D. M.; Clevenger, W.; Chalmers, D. T.; De Souza, E. B.; Oltersdorf, T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92:836–840; 1995.
Melzig, M. F. Corticotropin releasing factor inhibits proliferation of AtT-20 cells. In Vitro Cell. Dev. Biol. 30A:741–743; 1994.
Miyata, I.; Shiota, C.; Ikeda, Y.; Oshida, Y.; Chaki, S.; Okuyama, S.; Inagami, T. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amgdala. Biochem. Biophys. Res. Commun. 24:692–696; 1999.
Orth, D.N. Corticotropin-releasing hormone in humans. Endocr Rev. 13:164–191; 1992.
Owens, M. J.; Nemeroff, C. B. Physiology and pharmacology of corticotropin releasing factor. Pharmacol. Rev. 43:425–473; 1991.
Petraglia, F.; Santuz, M.; Florio, P., et al. Paracrine regulation of human placenta: control of hormonogenesis. J. Reprod. Immunol. 39:221–233; 1998.
Plotnikoff, N. P.; Faith, R. E.; Murgo, A. J.; Good, R. A. Cytokines: stress and immunity. Boca Raton, FL: CRC Press LLC; 1993.
Roloff, B.; Fechner, K.; Slominski, A., et al. Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors (CRF-R) in murine skin. FASEB J. 12:287–297; 1998.
Slominski, A.; Baker, J.; Ermak, G.; Chakraborty, A.; Pawelek, J. UVB stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett. 399:175–176; 1996a.
Slominski, A.; Botchkarev, V.; Choudhry, M., et al. Cutaneous expression of CRH and CRH-R: is there a “skin stress system”? Ann. N.Y. Acad. Sci. 885:287–311; 1999.
Slominski, A.; Ermak, G.; Hwang, J.; Chakraborty, A.; Mazurkiewicz, J.; Mihm, M. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374:113–116; 1995.
Slominski, A.; Ermak, G.; Hwang, J.; Mazurkiewicz, J.; Corliss, D.; Eastman, A. The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim. Biophys. Acta 1289:247–251; 1996b.
Slominski, A.; Ermak, G.; Mazurkiewicz, J. E.; Baker, J.; Wortsman, J. Characteriration of corticotropin releasing hormone (CRH) in human skin. J. Clin. Endocrinol. Metab. 83:1020–1024; 1998.
Slominski, A.; Mihm, M. Potential mechanism of skin response to stress. Int. J. Dermatol. 35:849–851; 1996.
Slominski, A.; Paus, R.; Wortsman, J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93: C1-C6; 1993.
Spiess, J.; Dautzenberg, F. M.; Sydow, S.; Hauger, R. L.; Ruhmann, A.; Blank, T.; Radulovic, J. Molecular properties of the CRF receptor. Trends Endocrinol. Metab. 9:140–145; 1998.
Tjuvajev, J.; Kolesnikov, Y.; Joshi, R. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 12:1–10; 1998.
Turnbull, A. V.; Vale, W.; Rivier, C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 303:213–216; 1996.
Vamvakopoulos, N. C.; Chrousos, G. P. Homonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr. Rev. 15: 409–420; 1994.
Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and b-endorphin. Science 213:1394–1397; 1981.
Van Wijk, P. A.; Van Neck, J. W.; Rijnberk, A.; Croughs, R. J.; Mol, H. A. Proliferation of the murine corticotropic tumor cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol. Cell. Endocrinol. 111:13–19; 1995.
Vaughan, J.; Donaldson, C.; Bittencourt, J., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287–292; 1995.
Vita, N.; Laurent, P.; Lefort, S., et al. Primary structure and functional expression of mouse pituitary and human corticotropin releasing factors receptors. FEBS Lett. 335:1–5; 1993.
Wei, E. T.; Gao, G. C.; Thomas, H. A. Peripheral anti-inflammatory actions of corticotropin-releasing factor. Ciba Found. Symp. 172:258–268, discussion 268–276; 1993.
Zhao, L.; Donaldson, C. J.; Smith, G. W.; Vale, W. W. The structures of the mouse and human urocortin genes (Ucn and UCN). Genomics 50:23–33; 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slominski, A.T., Roloff, B., Zbytek, B. et al. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell.Dev.Biol.-Animal 36, 211–216 (2000). https://doi.org/10.1290/1071-2690(2000)036<0211:CRHARP>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0211:CRHARP>2.0.CO;2